Reckitt Benckiser Group plc (LON:RKT – Get Free Report) insider Gavin Patterson acquired 191 shares of the firm’s stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of GBX 5,183 per share, with a total value of £9,899.53.
Reckitt Benckiser Group Stock Up 0.4%
Shares of Reckitt Benckiser Group stock traded up GBX 18 during trading on Friday, reaching GBX 5,134. The company had a trading volume of 15,331,688 shares, compared to its average volume of 23,399,000. The company has a market cap of £32.60 billion, a price-to-earnings ratio of 11.62, a price-to-earnings-growth ratio of 1.10 and a beta of 0.26. The firm’s fifty day moving average is GBX 5,067.22 and its 200-day moving average is GBX 5,145.53. The company has a debt-to-equity ratio of 179.24, a quick ratio of 0.46 and a current ratio of 0.59. Reckitt Benckiser Group plc has a fifty-two week low of GBX 3,866 and a fifty-two week high of GBX 6,522.92.
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported GBX 101.40 EPS for the quarter. Reckitt Benckiser Group had a return on equity of 42.87% and a net margin of 21.09%. On average, analysts anticipate that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.
Analyst Ratings Changes
Check Out Our Latest Stock Report on RKT
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
- BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
- Meta’s $18 Billion Settlement May Be a Win for Investors
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
